Ameritas Investment Company’s Quest Diagnostics DGX Stock Holding History

Ameritas Investment Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-533	Closed	-$68.5K	–	1041
2021 Q1	$68.5K	Buy	+533	New	+$65.7K	0.01%	868
2020 Q2	–	Sell	-202	Closed	-$16K	–	590
2020 Q1	$16K	Buy	+202	New	+$20.9K	﹤0.01%	1069
2019 Q4	–	Sell	-80	Closed	-$8K	–	985
2019 Q3	$8K	Buy	+80	New	+$8.21K	﹤0.01%	1163
2019 Q2	–	Sell	-177	Closed	-$16K	–	377
2019 Q1	$16K	Sell	177 -73	-29%	-$6.33K	﹤0.01%	585
2018 Q4	$21K	Buy	+250	New	+$23.4K	﹤0.01%	853

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ameritas Investment Company's DGX Position: Q2 2021 in Review

Ameritas Investment Company sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 533 shares — an estimated $68.5K sold.

Ameritas Investment Company first reported a position in DGX in Q4 2018 and held it in 5 quarters. The position peaked at $68.5K in Q1 2021. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

Ameritas Investment Company reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 533 Quest Diagnostics shares in Q2 2021, an estimated $68.5K.
Ameritas Investment Company first reported a position in Quest Diagnostics in Q4 2018 and held it in 5 quarters.
Ameritas Investment Company's Quest Diagnostics position peaked at $68.5K in Q1 2021.
815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.